Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

NowPatient vs Vytora Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

6.8

NowPatient

Best for Brand-name GLP-1 access without a compounded route
★★★☆☆3.4

Starting at $1069/mo

Brand NameFree Consultation
Visit NowPatient
8.7

Vytora Health

Best for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.
★★★★4.4

Starting at $150/mo

CompoundedBrand-Name Available (Mounjaro + Zepbound)All 50 States + DCLegitScript Approved
Visit Vytora Health

Side-by-Side Comparison

FeatureNowPatientVytora Health
Overall Score6.8/108.7/10
Starting Price$1069/mo$150/mo
Editorial Rating3.4 ★ /54.4 ★ /5
Features2 features10 features
States Available051
Compounded✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

NowPatient

Pros

  • Free telehealth consultation — patients only pay the medication cost
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few telehealth platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand

Cons

  • Cash-pay pricing tracks full brand list price (~$1,000-$1,350/mo)
  • Does not offer compounded semaglutide or tirzepatide (generally the cheaper route)
  • State availability not disclosed publicly — determined during intake
  • Phone: 1-866-967-1977, HQ Austin TX
  • Does NOT offer Foundayo (orforglipron)

Vytora Health

Pros

  • All 50 states + DC coverage with explicit per-state-modality compliance (video vs audio) disclosure
  • Both compounded AND brand-name options on a single platform — uncommon (most compounded-focused providers do not offer brand)
  • LegitScript Approved + HIPAA Compliant — both disclosed primary-source-verifiable
  • Pharmacy partners named publicly: Vials Pharmacy (TX) + Greenwich Biosciences — uncommon transparency
  • Owner / operating PC disclosed: Wasef Health, PC (Pinellas Park, FL)
  • Month-to-month pricing competitive ($180 sema / $249 tirz) and 3-month bundle (17% discount) for cost-sensitive patients
  • Brand-name Mounjaro and Zepbound available for patients who can self-pay $1,399/mo for FDA-approved options
  • Adjunct peptide offerings (NAD+, Sermorelin) for patients pursuing broader optimization regimens

Cons

  • Brand-name Mounjaro/Zepbound pricing ($1,399/mo) is near-retail; insured patients should pursue PA through traditional pharmacy + LillyDirect Self Pay Journey Program ($449-$699/mo) for better economics
  • Compounded tirzepatide tier ($249/mo) is above the lowest market floor ($149-199/mo) — Vytora pricing is mid-market for compounded
  • Specific dose-tier pricing not publicly broken out — pricing shown as 'all doses included' which is favorable but means high-dose patients pay the same as low-dose patients
  • Initial consultation cost not disclosed on public-facing pricing page (some providers free, some $99)
  • Limited primary-source-verifiable state licensure detail per individual prescriber (most multi-state telehealth platforms have this gap)

Our Verdict

Winner: Vytora HealthScore: 8.7/10

Vytora Health edges out NowPatient with a higher overall score of 8.7/10 and is particularly strong for Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.. NowPatient remains a solid alternative, especially if you're looking for Brand-name GLP-1 access without a compounded route.

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring NowPatient and Vytora Health head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.